Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.400
-0.080 (-5.41%)
Jul 31, 2026, 4:00 PM EDT - Market closed
PACB Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Sell Reiterates $1 → $1.5 | Sell | Reiterates | $1 → $1.5 | +7.14% | May 11, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates $3 | Buy | Reiterates | $3 | +114.29% | May 8, 2026 |
| Piper Sandler | Piper Sandler | Hold Reiterates $2 | Hold | Reiterates | $2 | +42.86% | May 8, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $3 | Buy | Reiterates | $3 | +114.29% | May 8, 2026 |
| Guggenheim | Guggenheim | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Feb 12, 2026 |